Atlas Arteria (OTCMKTS:MAQAF) Stock Price Down 10.5% – Here’s What Happened

Shares of Atlas Arteria Limited (OTCMKTS:MAQAF – Get Free Report) were down 10.5% during mid-day trading on Tuesday. The stock traded as low as $2.64 and last traded at $2.64. 360 shares traded hands during mid-day trading, a decline of 70% from the average daily volume of 1,203 shares. The stock had previously closed at $2.95.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the company. Royal Bank Of Canada cut Atlas Arteria to an “underperform” rating and set a $4.75 target price for the company. in a research note on Thursday, July 2nd. Jefferies Financial Group raised Atlas Arteria to a “buy” rating and set a $5.31 price target on the stock in a research note on Thursday, August 27th. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $5.03.

Check Out Our Latest Analysis on Atlas Arteria

Atlas Arteria Price Performance

The company’s 50-day moving average is $3.26 and its two-hundred day moving average is $3.34.

Atlas Arteria Company Profile

(Get Free Report)

Atlas Arteria Group is an owner and manager of transportation infrastructure assets, with a focus on toll roads and related concessions. The company invests in, develops and operates long-term road infrastructure under public-private partnership and concession arrangements, generating revenue from toll collections and other transportation-related activities.

Atlas Arteria’s portfolio includes interests in the APRR and AREA motorway networks in France, which together form one of the country’s major tolled motorway systems.

Recommended Stories

Receive News & Ratings for Atlas Arteria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atlas Arteria and related companies with MarketBeat.com's FREE daily email newsletter.